Medical News

RSS

Atrium Innovations acquires Enzimas

Atrium Innovations Inc., a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based dietary supplements endorsed by health professionals, today announced the acquisition of Enzimas S.A., a manufacturer of Trypsin and Chymotrypsin enzymes based in Lujan, Argentina.

19 Aug 2011

Viewpoints: 'Judicial restraint' and health law; mental health parity; perspectives from JAMA and NEJM

A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge -- starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.

19 Aug 2011

More kids being diagnosed with ADHD

A new study revealed that number of children diagnosed with Attention Deficit Hyperactivity disorder or ADHD has risen sharply over the last decade.

18 Aug 2011

Women being screened too often for cervical cancer

Researchers based at the Centers for Disease Control and Prevention (CDC) found that many primary care doctors would bring women back for cancer screening annually - while recommendations generally call for a three-year wait after normal tests. This translates to higher costs to women and the healthcare system, as well as a risk of unnecessary treatment for false-positive test results - with very little additional cancer-catching benefit say experts. Lead author Katherine Roland said, “There's really no advantage to annual screening compared to screening every two or three years.”

18 Aug 2011

Bill Clinton on being ‘vegan’

Former President Bill Clinton has revealed that his diet is turning plant-based and heart-healthy. He said he believes the vegan regimen is helping to reverse the damage to his heart and blood vessels caused by cardiovascular disease.

18 Aug 2011

Flu immunization targets fall short for health workers and pregnant women

According to a new survey despite recent improvements in influenza vaccination rates among U.S. health care personnel, their rates for the 2010-2011 flu season still fell short of national health objectives.

18 Aug 2011

Medical research funding boost in UK

Health researchers in Cambridge have been awarded £114.5m to develop and translate new scientific discoveries into medicines and treatments. The funds come as a part of a five-year £800m investment by the National Institute for Health Research (NIHR).

18 Aug 2011

Mosquitoes fast to develop resistance against insecticide-treated bed nets

According to a study from Senegal mosquitoes are quick to develop resistance to insecticide-treated nets. This has raised concerns that a leading method of preventing the disease may be less effective than previously thought.

18 Aug 2011

Australian youth mostly ignorant about sexual health

The survey found that most of the young people do not know about Pap smears, sexually transmitted infections and how the contraceptive pill works.

18 Aug 2011

Gene Security Network announces commercial launch of non-invasive prenatal test

Gene Security Network Inc. (GSN) today announced the commercial launch of its first non-invasive prenatal test powered by the company's proprietary bioinformatics technology, Parental Support™.

18 Aug 2011

Medical Connections second quarter revenue decreases 6.8% to $1,779,938

Medical Connections Holdings, Inc. a national provider of healthcare staffing services, announced today its operating results for the second quarter and the first six months of 2011. Revenue for the second quarter of 2011 was $1,779,938, a decrease of 6.8% when compared to the second quarter of 2010.

18 Aug 2011

NPS submits NDA CMC section to FDA for GATTEX

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has submitted the chemistry, manufacturing and controls (CMC) section of its new drug application (NDA) for GATTEX® (teduglutide) to the U.S. Food and Drug Administration (FDA).

18 Aug 2011

Scientists artificially grow brain cells from Parkinson's patients to find treatment

The UK's population is ageing and with it comes an increased risk of developing age-related diseases such as Parkinson's. About 70% of dopamine producing brain cells will have been lost by the time a sufferer visits the doctor, with symptoms that include difficulties with movement and a resting tremor. A progressive neurodegenerative disease, Parkinson's affects about 120,000 people in the UK.

18 Aug 2011

AHRQ awards Johns Hopkins Evidence-based Practice Center $475,000 for study on effective wound care

An estimated $25 billion is spent annually on treating chronic wounds on patients in the United States. These chronic wounds deeply affect the quality of life of more than six million people who have them. The most common types of chronic skin wounds and skin ulcers are related to venous disease (conditions related to or caused by veins that become diseased or abnormal).

18 Aug 2011

First Edition: August 18, 2011

"The SSI program for children is rapidly expanding, with the biggest increase among kids with mental, behavioral and learning disorders, including ADHD, speech delays, autism, and bipolar disorder. But as it pulls in children like Hulston, the program is sparking criticism in Congress.

18 Aug 2011

PrEP raises questions regarding 'risk disinhibition' and drug resistance

Nature News reports on "the possibility of unintended public-health consequences" of pre-exposure prophylaxis (PrEP) for HIV and pharmaceutical company Gilead's plan to ask the FDA to evaluate its combination antiretroviral (ARV) drug Truvada for use in healthy people.

18 Aug 2011

Cortex second quarter net loss decreases to $356,000

Cortex Pharmaceuticals, Inc. reported a net loss of approximately $356,000, or $0.00 per share, for the quarter ended June 30, 2011, compared with a net loss of approximately $2,454,000, or $0.04 per share, for the corresponding prior year period, with the difference reflecting revenues in the current year period from the Company's option agreement with Servier, France's largest privately held pharmaceutical company.

18 Aug 2011

ProtoKinetix completes sale of AAGP tool for protecting delicate cells in research

ProtoKinetix, announces today that it has completed the sale of (AAGP) as a vital tool to protect delicate cells in the process of utilizing stem cells, to treat disease and injury. This development will enable the Company to ramp up sales of the unique AAGP family of molecules to the medical research community.

18 Aug 2011

Lucentis receives Health Canada approval for treatment of retinal vein occlusion

Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.

18 Aug 2011

Tobacco companies sue federal government over graphic warnings

Tobacco companies want a judge to put a stop to new graphic cigarette labels that include the sewn-up corpse of a smoker and pictures of diseased lungs, saying they unfairly urge adults to shun their legal products and will cost millions to produce.

18 Aug 2011